ELAVL1 and glioma: Therefore, we suggest that glioma stem cells with cell-cycle checkpoint abnormalities, genomic instabilities, and renewal abilities hijack HuR function in stressed glioma microenvironments to advance glioma heterogeneity and proliferation.